drugset / Trial / NCT00396630

A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.

NCT00396630

Phase 3 Completed 200 enrolled GlaxoSmithKline
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of this study is to explore horizontal transmission of the HRV (Human Rotavirus) vaccine strain within a family from the twin vaccinated with Rotarix to the twin receiving placebo. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.

Timeline

Start
2007-01-23
Primary completion
2008-01-23
Completion
2008-02-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Rotarix Vaccine Oral

Indications